Identification of the descriptor pharmacophores using variable selection QSAR: applications to database mining
Related Experiment Video
Updated: Aug 8, 2026

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
Published on: August 28, 2019
1The Laboratory for Molecular Modeling, Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA. tropsha@email.unc.edu
Abstract:
The pharmacophore concept is central to the rational drug design and discovery process. Traditionally, a pharmacophore is defined as a specific three-dimensional (3D) arrangement of chemical functional groups found in active molecules, which are characteristic of a certain pharmacological class of compounds. Herein, by analogy with 3D pharmacophores, a more general concept of descriptor pharmacophore is introduced. The descriptor pharmacophores are defined by the means of variable selection QSAR as a subset of molecular descriptors that afford the most statistically significant structure-activity correlation. The two variable selection QSAR methods developed in this laboratory are discussed; these include Genetic Algorithms--Partial Least Squares (GA-PLS) and K-Nearest Neighbors (KNN). Both methods employ multiple topological descriptors of chemical structures such as molecular connectivity indices or atom pairs (AP), and stochastic optimization algorithms to achieve a robust QSAR model, which is characterized by the highest value of cross-validated R2 (q2). By default, the descriptor pharmacophore represents an invariant selection of descriptor types however, descriptor values are generally different for different molecules. We demonstrate that chemical similarity searches using descriptor pharmacophores as opposed to using all descriptors afford more efficient mining of chemical databases or virtual libraries to discover compounds with a desired biological activity.
More Related Videos
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
05:50Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
Published on: September 26, 2025
Related Concept Videos
Drug Discovery: Overview
Quantitative Aspects of Drug-Receptor Interaction
Analysis of Population Pharmacokinetic Data
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Pharmacogenomics: Identification of New Drug Targets